Beste apotheek van Nederland

Christ B, Brockmeier D, Hauck E W et al. Investigation on
interaction between tacrolimus and sildenafil in kidneytransplanted
patients with erectile dysfunction. International
Journal of Clinical Pharmacology & Therapeutics
2004;42(3):149-156.
Christ G J, Melman A. The application of gene therapy to the
treatment of erectile dysfunction. Int J Impot Res
1998;10(2):111-112.
Chun S S, Fenemore J, Heaton J P et al. Enhancement of erectile
responses to vasoactive drugs by a variable amplitude oscillation
device. Int J Impot Res 1996;8(4):221-225.
Clark C. Erectile dysfunction and other problems. Can Pharm J
2004;272(7299):608-610.
Claro J A, Ximenes S F, Nardozza A et al. Effect of sildenafil in
cavernous arteries of patients with erectile dysfunction.
International Braz J Urol 2003;29(4):320-326.
Cohen J S. Comparison of FDA reports of patient deaths
associated with sildenafil and with injectable alprostadil. Ann
Pharmacother 2001;35(3):285-288.
Conti C R, Pepine C J, Sweeney M. Efficacy and safety of
sildenafil citrate in the treatment of erectile dysfunction in
patients with ischemic heart disease. Am J Cardiol
1999;83(5A):29C-34C.
Cooper A J. Evaluation of I-C papaverine in patients with
psychogenic and organic impotence. Canadian Journal of
Psychiatry - Revue Canadienne de Psychiatrie 1991;36(8):574­
578.
Copel L, Katz R, Blachar A et al. Clinical and duplex US
assessment of effects of sildenafil on cavernosal arteries of the
penis: Comparison with intracavernosal injection of vasoactive
agents - Initial experience. Radiology 2005;237(3):986-991.
Corona G, Mannucci E, Fisher A D et al. Effect of
hyperprolactinemia in male patients consulting for sexual
dysfunction. Br J Sex Med 2007;4(5):1485-1493.
Corona G, Mannucci E, Schulman C et al. Psychobiologic
correlates of the metabolic syndrome and associated sexual
dysfunction. Eur Urol 2006;50(3):595-604.
Costabile R A, Spevak M, Fishman I J et al. Efficacy and safety
of transurethral alprostadil in patients with erectile dysfunction
following radical prostatectomy. Br J Urol 1998;160(4):1325­
1328.
Crowe S M, Streetman D S. Vardenafil treatment for erectile
dysfunction. [Review] [43 refs]. Ann Pharmacother
2004;38(1):77-85.
Curran M, Keating G. Tadalafil.[erratum appears in Drugs.
2003;63(23):2703]. [Review] [31 refs]. Drugs
2003;63(20):2203-2212.
Dachille G, Pagliarulo V, Ludovico G M et al. Sexual
dysfunction in patients under dialytic treatment.
Minerva Urol Nefrol 2006;58(2):195-200.
Davis B E, Weigel J W, Whitford C S. Treatment of
male impotence: a new option. Kans Med
1990;91(12):325-326.
De Rose A F, Giglio M, Traverso P et al. Combined
oral therapy with sildenafil and doxazosin for the
treatment of non-organic erectile dysfunction
refractory to sildenafil monotherapy. Int J Impot Res
2002;14(1):50-53.
De Meyer J M, Thibo P, Hatzichriston D G. The effect
of re-dosing of vasodilators on the intracavernosal
pressure and on the penile rigidity. Eur Urol
1998;33(3):293-297.
De Siati M, Saugo M, Franzolin N. The start of
pharmacological activity after sublingual
administration of sildenafil citrate in 30 patients
affected by erectile dysfunction. Arch Ital Urol Androl
2003;75(1):18-20.
Decter R M, Furness P D, Nguyen T A et al.
Reproductive understanding, sexual functioning and
testosterone levels in men with spina bifida. Br J Urol
1997;157(4):1466-1468.
Derby C A, Araujo A B, Johannes C B et al.
Measurement of erectile dysfunction in populationbased
studies: the use of a single question selfassessment
in the Massachusetts Male Aging Study.
Int J Impot Res 2000;12(4):197-204.
Derry F, Hultling C, Seftel A D et al. Efficacy and
safety of sildenafil citrate (Viagra) in men with
erectile dysfunction and spinal cord injury: a review.
Urology 2002;60(2 Suppl 2):49-57.
Dhabuwala C B, Kerkar P, Bhutwala A et al.
Intracavernous papaverine in the management of
psychogenic impotence. Arch Androl 1990;24(2):185­
191.
Dinsmore W W. Medical treatment of impotence with
papaverine and phentolamine intracavernosal
injection. Ulster Med J 1990;59(2):174-176.
Dinsmore W W, Alderdice D K. Vasoactive intestinal
polypeptide and phentolamine mesylate administered
by autoinjector in the treatment of patients with
erectile dysfunction resistant to other intracavernosal
agents. Br J Urol 1998;81(3):437-440.
Dizon M N, Vesely D L. Gonadotropin-secreting
pituitary tumor associated with hypersecretion of
testosterone and hypogonadism after
hypophysectomy. Endocr Pract 2002;8(3):225-231.
D-165